Evaluation of low-dose colchicine in patients with cardiopulmonary bypass: study protocol for a randomised controlled trial

INTRODUCTION: Inflammation and myocardial damage caused by cardiovascular surgery with cardiopulmonary bypass (CPB) have been shown to be the major contributors to postoperative morbidity and mortality. Colchicine can reduce myocardial ischaemia-reperfusion injury in patients with chronic coronary a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, He, Han, Xikun, Pan, Tuo, Zhang, Hai-Tao, Zhong, Kai, Li, Ze-Shi, Jiang, Xinyi, Pan, Jun, Wang, Dong-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808419/
https://www.ncbi.nlm.nih.gov/pubmed/35105570
http://dx.doi.org/10.1136/bmjopen-2021-050577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808419/
https://www.ncbi.nlm.nih.gov/pubmed/35105570
http://dx.doi.org/10.1136/bmjopen-2021-050577

Ejemplares similares